2CUREX — 2cureX AB Share News
0.000.00%
Last trade - 00:00- SEK12.00m
- SEK9.90m
Brief: 2cureX Gets Approval For Start Of Clinical Trial In Pancreatic Cancer
Brief: 2Curex Q2 Pre-Tax Loss Widens To SEK 3.1 Million
Brief: 2Curex AB Strengthens Its Patent Portfolio With New Approved European Patent
Brief: 2Curex AB To Present Positive Data From Clinical Study With Inditreat At Esmo In Barcelona
Brief: 2CureX Q1 Pretax Loss Widens To SEK 2.9 Million
Brief: 2cureX Opens Lab In Hamburg
Brief: 2CureX Gets First Payment Of EUR 1.5 Million From Horizon 2020
Brief: 2Curex AB Q4 Net Sales Amounted To SEK 457,000